NASDAQ:SBFM
Sunshine Biopharma, Inc.
- Stock
Last Close
0.89
17/05 20:00
Market Cap
6.52M
Beta: −1.00
Volume Today
3.85M
Avg: 127.64K
PE Ratio
−0.22
PFCF: −0.67
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | -1.56K - | -1.56K 0% | -4.83K 210.74% | -4.83K 0% | 7.96K 264.58% | 19.84K 149.41% | 64.71K 226.15% | 1.70M 2,523.68% | 4.51M 165.78% | |||
average payables | 12.20K - | 29.29K 140.02% | 40.68K 38.89% | 37.36K 8.17% | 23.72K 36.51% | 105.20K 343.53% | 143.98K 36.87% | 79.88K 44.52% | 52.91K 33.76% | 1.42M 2,589.43% | 1.40M 1.51% | |
average receivables | 1.56K - | 1.56K 0% | 4.83K 210.74% | 52.31K 982.26% | 47.69K 8.83% | 1.17K 97.54% | 4.86K 314.07% | 959.98K 19,664.78% | 2.23M 132.53% | |||
book value per share | -10.24 - | -421.74 4,018.95% | -390.74 7.35% | -39.49 89.89% | -52.56 33.10% | -3.66 93.04% | -13.45 267.59% | -0.94 93.04% | 0.08 108.66% | 1.42 1,658.13% | 0.87 38.82% | |
capex per share | -408.12 - | -0.65 99.84% | -0.34 47.37% | -1.24 263.02% | -0.02 98.73% | -0.00 92.58% | -0.02 - | |||||
capex to depreciation | -146.70 - | -0.06 99.96% | -0.56 890.47% | -0.38 31.91% | -0.06 83.65% | -0.08 35.61% | -12.12 - | |||||
capex to operating cash flow | 0.72 - | 0.01 98.48% | 0.01 37.51% | 0.04 437.36% | 0.00 95.28% | 0.00 4.46% | 0.06 - | |||||
capex to revenue | -365.11 - | -0.04 - | -0.04 3.40% | -0.02 59.04% | -0.07 - | |||||||
cash per share | 41.49 - | 156.06 276.17% | 33.24 78.70% | 10.82 67.45% | 9.86 8.89% | 7.56 23.28% | 0.74 90.20% | 0.97 30.92% | 0.78 19.28% | 1.44 83.63% | 0.67 53.43% | |
days of inventory on hand | 525.53 - | 335.68 36.13% | 327.27 2.51% | 453.31 38.51% | 66.44 85.34% | |||||||
days payables outstanding | 178.34 - | 3.20K 1,694.45% | 887.82 72.26% | 133.02 85.02% | 386.19 190.32% | |||||||
days sales outstanding | 664.82 - | 77.50 - | 7.43 90.41% | 9.79 31.79% | 12.46 27.23% | 160.61 1,188.95% | 23.38 85.44% | |||||
debt to assets | 0.40 - | 3.35 736.63% | 1.69 49.39% | 3.68 117.19% | 3.12 15.31% | 0.83 73.34% | 7.29 777.58% | 1.83 74.90% | 0.86 52.87% | 0.15 83.05% | ||
debt to equity | -1.62 - | -1.24 23.59% | -1.91 54.21% | -1.13 40.85% | -1.40 23.83% | -17.09 1,121.03% | -0.97 94.31% | -2.00 105.91% | 8.98 548.02% | 0.20 97.80% | ||
dividend yield | ||||||||||||
earnings yield | -1.10K - | -3.83K 248.12% | -4.16K 8.72% | -8.23K 97.84% | -400.69 95.13% | -8.85K 2,107.68% | -59.41K 571.62% | -56.03 99.91% | -83.61 49.23% | -2.75 96.71% | -0.68 75.22% | |
enterprise value | -16.47K - | 337.21K 2,146.97% | 1.09M 223.29% | 179.94K 83.49% | 697.38K 287.56% | 837.63K 20.11% | 675.09K 19.40% | 939.25K 39.13% | 7.51K 99.20% | -7.84M 104,475.14% | -9.69M 23.60% | |
enterprise value over ebitda | 0.01 - | -0.19 2,358.02% | -1.40 631.19% | -0.19 86.26% | -0.75 289.60% | -0.42 43.99% | -0.72 70.05% | -0.36 49.89% | -0.00 99.14% | 0.96 31,262.69% | 2.36 145.16% | |
ev to operating cash flow | 0.03 - | -0.63 2,245.03% | -1.26 100.69% | -0.57 54.42% | -1.28 124.03% | -1.63 27.30% | -1.36 16.64% | -1.43 4.95% | -0.00 99.71% | 1.49 36,476.23% | 1.10 26.07% | |
ev to sales | 638.27 - | 1.87 - | 31.96 1,606.46% | 13.15 58.85% | 0.03 99.75% | -1.80 5,586.46% | -0.24 86.52% | |||||
free cash flow per share | -749.53 - | -586.07 21.81% | -975.95 66.52% | -59.82 93.87% | -50.17 16.13% | -34.90 30.44% | -9.09 73.97% | -0.65 92.90% | -0.70 8.52% | -0.37 47.76% | -0.36 1.41% | |
free cash flow yield | -249.01 - | -1.07K 327.92% | -3.75K 252.26% | -747.70 80.08% | -210.79 71.81% | -2.18K 934.77% | -20.19K 825.65% | -41.10 99.80% | -11.98 70.85% | -0.57 95.23% | -1.33 132.40% | |
graham net net | -10.24 - | -421.74 4,018.95% | -797.60 89.12% | -40.80 94.88% | -66.09 61.98% | -66.69 0.90% | -14.36 78.47% | -0.98 93.19% | 0.04 104.41% | 1.14 2,541.68% | 0.61 46.11% | |
graham number | 873.08 - | 4.47K 411.87% | 3.08K 30.99% | 764.93 75.20% | 335.84 56.10% | 107.96 67.85% | 89.96 16.67% | 4.30 95.22% | 2.98 30.64% | 7.51 151.75% | 1.91 74.64% | |
income quality | 0.23 - | 0.28 22.92% | 0.53 88.59% | 0.09 82.89% | 0.52 481.51% | 0.24 54.48% | 0.30 25.56% | 0.24 20.94% | 0.15 37.70% | 0.20 33.43% | 1.95 892.36% | |
intangibles to total assets | 0 - | 0 | 0.91 Infinity% | 0 100% | 0 | 0.58 Infinity% | 0 100% | 0 | 0 | 0.03 Infinity% | 0.05 98.81% | |
interest coverage | -299.93 - | -9.80 96.73% | -2.54 74.08% | -28.59 1,025.78% | -8.18 71.40% | -7.32 10.51% | -5.54 24.34% | -3.43 38.01% | -7.42 116.25% | -220.09 2,865.75% | 34.85 115.84% | |
interest debt per share | 25.17 - | 717.32 2,749.61% | 947.50 32.09% | 51.17 94.60% | 83.16 62.53% | 73.00 12.23% | 15.21 79.16% | 2.04 86.59% | 0.85 58.16% | 0.28 66.70% | -0.01 101.99% | |
inventory turnover | 0.69 - | 1.09 56.56% | 1.12 2.57% | 0.81 27.80% | 5.49 582.33% | |||||||
invested capital | -1.62 - | -1.24 23.59% | -1.91 54.21% | -1.13 40.85% | -1.40 23.83% | -17.09 1,121.03% | -0.97 94.31% | -2.00 105.91% | 8.98 548.02% | 0.20 97.80% | ||
market cap | 2.27K - | 505.45 77.70% | 397.28 21.40% | 424.80 6.93% | 2.60K 511.14% | 243.74 90.61% | 24.60 89.91% | 16.02K 65,031.50% | 152.67K 852.93% | 9.72M 6,263.69% | 6.61M 32.01% | |
net current asset value | -7.71K - | -387.58K 4,926.98% | -1.22M 213.84% | -215.64K 82.27% | -713.65K 230.94% | -990.81K 38.84% | -767.84K 22.50% | -974.37K 26.90% | 204.60K 121.00% | 19.70M 9,526.57% | 18.75M 4.80% | |
net debt to ebitda | 0.01 - | -0.19 2,081.95% | -1.40 632.02% | -0.19 86.29% | -0.75 289.07% | -0.42 43.80% | -0.72 70.10% | -0.35 50.75% | 0.06 116.95% | 2.16 3,509.95% | 3.97 84.11% | |
net income per share | -3.31K - | -2.10K 36.39% | -1.08K 48.60% | -658.51 39.13% | -95.36 85.52% | -141.54 48.42% | -26.73 81.11% | -0.88 96.71% | -4.89 455.56% | -1.76 63.95% | -0.19 89.49% | |
operating cash flow per share | -749.53 - | -586.07 21.81% | -567.83 3.11% | -59.17 89.58% | -49.83 15.79% | -33.66 32.44% | -9.07 73.06% | -0.64 92.90% | -0.70 8.72% | -0.35 50.63% | -0.36 4.32% | |
payables turnover | 2.05 - | 0.11 94.43% | 0.41 260.45% | 2.74 567.43% | 0.95 65.56% | |||||||
receivables turnover | 0.55 - | 4.71 - | 49.12 942.95% | 37.27 24.12% | 29.29 21.40% | 2.27 92.24% | 15.61 586.94% | |||||
research and ddevelopement to revenue | 5.07 - | 0.03 - | 0.72 2,414.98% | 0.85 18.57% | 2.94 244.79% | 0.19 93.65% | ||||||
return on tangible assets | -79.75 - | -13.49 83.09% | -28.39 110.51% | -54.29 91.24% | -4.04 92.56% | -4.48 10.99% | -14.89 232.11% | -0.86 94.23% | -5.79 574.88% | -0.94 83.79% | -0.17 81.48% | |
revenue per share | 1.12 - | 29.36 - | 0.39 98.68% | 0.07 81.89% | 0.09 24.97% | 0.29 227.33% | 1.64 472.08% | |||||
roe | 323.15 - | 4.99 98.46% | 2.77 44.52% | 16.67 502.31% | 1.81 89.12% | 38.67 2,031.62% | 1.99 94.86% | 0.94 52.69% | -60.31 6,514.95% | -1.24 97.95% | -0.21 82.82% | |
roic | -493.25 - | -18.97 96.16% | -1.93 89.84% | -62.13 3,124.65% | -3.75 93.97% | -1.28 65.97% | 43.89 3,540.80% | -0.19 100.44% | -1.19 511.08% | -0.33 72.21% | -0.25 24.97% | |
sales general and administrative to revenue | 450.28 - | 2.70 - | 29.48 991.99% | 7.67 74.00% | 8.17 6.55% | 2.05 74.93% | 0.33 83.92% | |||||
shareholders equity per share | -10.24 - | -421.74 4,018.95% | -390.74 7.35% | -39.49 89.89% | -52.56 33.10% | -3.66 93.04% | -13.45 267.59% | -0.94 93.04% | 0.08 108.66% | 1.42 1,658.13% | 0.87 38.82% | |
stock based compensation to revenue | ||||||||||||
tangible asset value | -7.71K - | -387.58K 4,926.98% | -1.21M 212.73% | -209.70K 82.70% | -573.36K 173.42% | -721.45K 25.83% | -735.38K 1.93% | -954.84K 29.84% | 211.66K 122.17% | 20.85M 9,750.95% | 19.76M 5.22% | |
tangible book value per share | -10.24 - | -421.74 4,018.95% | -793.25 88.09% | -39.49 95.02% | -52.56 33.10% | -47.36 9.90% | -13.45 71.59% | -0.94 93.04% | 0.08 108.66% | 1.42 1,658.13% | 0.81 42.99% | |
working capital | -7.71K - | -387.58K 4,926.98% | -1.22M 213.84% | -215.64K 82.27% | -633.94K 193.97% | -700.97K 10.57% | -767.84K 9.54% | -25.36K 96.70% | 2.10M 8,398.25% | 20.38M 868.42% | 19.34M 5.12% |
All numbers in USD (except ratios and percentages)